Logo image of BIVI

BIOVIE INC (BIVI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BIVI - US09074F5044 - Common Stock

1.35 USD
0 (0%)
Last: 11/25/2025, 8:27:00 PM
1.37 USD
+0.02 (+1.48%)
After Hours: 11/25/2025, 8:27:00 PM
Fundamental Rating

2

Overall BIVI gets a fundamental rating of 2 out of 10. We evaluated BIVI against 533 industry peers in the Biotechnology industry. The financial health of BIVI is average, but there are quite some concerns on its profitability. BIVI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BIVI has reported negative net income.
BIVI had a negative operating cash flow in the past year.
In the past 5 years BIVI always reported negative net income.
In the past 5 years BIVI always reported negative operating cash flow.
BIVI Yearly Net Income VS EBIT VS OCF VS FCFBIVI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -83.07%, BIVI is doing worse than 68.67% of the companies in the same industry.
The Return On Equity of BIVI (-94.21%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -83.07%
ROE -94.21%
ROIC N/A
ROA(3y)-119.07%
ROA(5y)-705.14%
ROE(3y)-211.57%
ROE(5y)-997.19%
ROIC(3y)N/A
ROIC(5y)N/A
BIVI Yearly ROA, ROE, ROICBIVI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BIVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BIVI Yearly Profit, Operating, Gross MarginsBIVI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, BIVI has more shares outstanding
The number of shares outstanding for BIVI has been increased compared to 5 years ago.
BIVI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BIVI Yearly Shares OutstandingBIVI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
BIVI Yearly Total Debt VS Total AssetsBIVI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

BIVI has an Altman-Z score of -22.14. This is a bad value and indicates that BIVI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BIVI (-22.14) is worse than 85.55% of its industry peers.
BIVI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -22.14
ROIC/WACCN/A
WACCN/A
BIVI Yearly LT Debt VS Equity VS FCFBIVI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M -40M

2.3 Liquidity

A Current Ratio of 9.10 indicates that BIVI has no problem at all paying its short term obligations.
BIVI's Current ratio of 9.10 is fine compared to the rest of the industry. BIVI outperforms 79.36% of its industry peers.
A Quick Ratio of 9.10 indicates that BIVI has no problem at all paying its short term obligations.
With a decent Quick ratio value of 9.10, BIVI is doing good in the industry, outperforming 79.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.1
Quick Ratio 9.1
BIVI Yearly Current Assets VS Current LiabilitesBIVI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

BIVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.14%, which is quite impressive.
EPS 1Y (TTM)81.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

BIVI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.24% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y86.39%
EPS Next 2Y72.68%
EPS Next 3Y69.51%
EPS Next 5Y60.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BIVI Yearly Revenue VS EstimatesBIVI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2031 2032 50M 100M 150M 200M 250M
BIVI Yearly EPS VS EstimatesBIVI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BIVI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BIVI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BIVI Price Earnings VS Forward Price EarningsBIVI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIVI Per share dataBIVI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as BIVI's earnings are expected to grow with 69.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.68%
EPS Next 3Y69.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BIVI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIOVIE INC

NASDAQ:BIVI (11/25/2025, 8:27:00 PM)

After market: 1.37 +0.02 (+1.48%)

1.35

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10 2025-11-10
Earnings (Next)02-09 2026-02-09
Inst Owners1.53%
Inst Owner Change7.77%
Ins Owners0.21%
Ins Owner Change0%
Market Cap10.18M
Revenue(TTM)N/A
Net Income(TTM)-17.91M
Analysts82.86
Price Target61.2 (4433.33%)
Short Float %2.93%
Short Ratio1.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.09%
PT rev (3m)9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.54
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)-14.93
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)-2.52
FCFYN/A
OCF(TTM)-2.52
OCFYN/A
SpS0
BVpS2.52
TBVpS2.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -83.07%
ROE -94.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-119.07%
ROA(5y)-705.14%
ROE(3y)-211.57%
ROE(5y)-997.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.1
Quick Ratio 9.1
Altman-Z -22.14
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.76%
EPS Next Y86.39%
EPS Next 2Y72.68%
EPS Next 3Y69.51%
EPS Next 5Y60.24%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.92%
OCF growth 3YN/A
OCF growth 5YN/A

BIOVIE INC / BIVI FAQ

What is the fundamental rating for BIVI stock?

ChartMill assigns a fundamental rating of 2 / 10 to BIVI.


What is the valuation status for BIVI stock?

ChartMill assigns a valuation rating of 1 / 10 to BIOVIE INC (BIVI). This can be considered as Overvalued.


How profitable is BIOVIE INC (BIVI) stock?

BIOVIE INC (BIVI) has a profitability rating of 0 / 10.


How financially healthy is BIOVIE INC?

The financial health rating of BIOVIE INC (BIVI) is 6 / 10.


What is the earnings growth outlook for BIOVIE INC?

The Earnings per Share (EPS) of BIOVIE INC (BIVI) is expected to grow by 86.39% in the next year.